Finanzen von Klotho Neurosciences Inc (KLTO)KLTOKlotho Neurosciences Inc

Evaluating the bottom line, Klotho Neurosciences Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at N/A, while the net margin is N/A. These profitability ratios, combined with a Return on Equity (ROE) of -198.28%, provide a clear picture of how effectively KLTO converts its operational activities into shareholder value.

In the context of the broader market, KLTO competes directly with industry leaders such as CELU and AACG. With a market capitalization of N/A, it holds a significant position in the sector. When comparing efficiency, KLTO's gross margin of N/A stands against CELU's -88.86% and AACG's 56.37%. Such benchmarking helps identify whether Klotho Neurosciences Inc is trading at a premium or discount relative to its financial performance.

In Q3 2025, the company reported zero revenue growth, a net income drop to -2.16% YoY, and a significant EPS decline of -72.22% YoY. Gross margin remained at 0%.